February 27, 2026

Can Testosterone Affect Cognitive Function? 

Systematic review finds modest, population-dependent effects on mood and cognition in adult men 

Conexiant

February 25, 2026

Medical Oddities: For the Birds—and the Brain

Birds for brains, blackout laughs, anti-aging tea, thin air, muscle memory—and torn marriages, all with a clinical touch this week.

Conexiant

February 23, 2026

FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

Conexiant

February 23, 2026

Digital Resilience Training Reduces PTSD Risk

Randomized trial suggests targeted cognitive training may prevent trauma-related disorders in paramedics

Conexiant

February 19, 2026

Telehealth Patterns in Medicare Beneficiaries

One in six Medicare beneficiaries used telehealth between 2021 and 2023, with mental health visits leading the way, states new research report.

Conexiant

February 17, 2026

CKD Markers Linked to Cognitive Risk

In adults with chronic kidney disease, higher proteinuria and lower estimated glomerular filtration rate are associated with increased risk of incident cognitive impairment.

Conexiant

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 12, 2026

FDA Approves HRT Label Changes

The agency cited updated evidence in revising hormone therapy safety language.

Conexiant

February 12, 2026

Treating Loneliness as a Clinical Risk

Trial informs scalable behavioral health approaches for socially isolated older adults

Conexiant